Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the alarming trend of increasing ACS hospitalizations and higher in-hospital mortality among young and middle-aged women, emphasizing the need for better risk characterization and prevention.
This editorial refers to ‘Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–14’†, by A. Gabet et al., on page 1060. Our knowledge is a little island in a great ocean of non-knowledge Isaac Bashevis Singer In this issue of the journal, Gabet et al. now provide additional evidence for these alarming tendencies by reporting a significant increase in ACS hospitalizations in females aged <65 years, with the most pronounced rise seen in young women aged 45–54 years admitted for ST-elevation myocardial infarction (STEMI).5 The authors investigated recent trends in the annual incidence of ACS in France and analysed hospitalization data between 2004 and 2014. In contrast to their observations in younger females, the authors found a significant reduction in ACS admission rates for elderly women and men. In-hospital mortality was higher in women than in men, and this mortality gap between sexes was most pronounced in patients admitted for STEMI. Importantly, these trends resulted in a significant decrease of mean age at ACS admission in women but not in men during the study period. Cardiovascular (CV) risk factors (RFs) with higher prevalence and greater clinical significance in young women as compared with men and/or older women. CAD, coronary artery disease; MI, myocardial infarction. *Further increases risk in women with high baseline CV risk; risk increases with higher doses of oestrogens. **Two-fold more frequent in women than in men among patients with ST-elevation myocardial infarction (STEMI). Image reproduced with permission from MediDesign Frank Geisler. It is known on the basis of a very large sample size that women presenting with ACS are on average 10 years older than males. This age ‘gap’ in the occurrence of CAD has mainly been attributed to the protective role of oestrogens in the cardiovascular system. Gabet et al. now indicate that this 10-year difference between males and females presenting with ACS is gradually narrowing by reporting a significant decrease of mean age at ACS admission in women but an opposite trend in men. These intriguing data prompt the question of whether the protective role of oestrogens in young females is being overtaken by an ever-increasing number of cardiovascular risk factors. Indeed, the sex difference for age at first ACS has largely been explained by a higher risk burden at younger age in men as compared with women. The study by Gabet et al. now indicates that young women are catching up with their male counterparts and may have profited less from recent advances in preventive treatments. Baseline cardiovascular risk in young women represents a largely modifiable target. Thus, better characterization of cardiovascular risk profiles in women and the development of effective primary prevention strategies should lead the debate in the future. In women, the window of opportunity to prevent CAD is open in the pre-menopausal years. Gabet et al. now demonstrate that this window is getting smaller. Another issue still actively debated is whether there are still inequalities in diagnosis and treatment in women, leading to a gender gap in outcomes among patients with ACS. Gabet et al. report in their study an excess risk for in-hospital mortality in women presenting with ACS, thereby indicating that gender disparities in patients with ACS persist in contemporary practice. While the authors do not provide age-specific outcome data, previous reports indicate a lower survival following ACS in younger women.4 Atypical symptoms, delay in seeking care, underutilization of evidence-based therapies, and a higher rate of complications have been suggested to account for these findings. In addition, a major role in gender disparities in ACS outcomes has been attributed to female coronary pathophysiology. In fact, their higher susceptibility to coronary microvascular dysfunction has been suggested to present a hidden biological risk. Accordingly, impaired coronary flow reserve (CFR) in the absence of obstructive CAD has recently been associated with excess cardiovascular risk in women.13 A greater perception of mental stress, a higher rate of recurrent hospitalizations, lower rates of return to work, low adherence to prescribed therapies, as well as underutilization of cardiac rehabilitation therapies in young women with ACS have also been reported, and highlight the need for more targeted strategies in secondary prevention in this population.14 In this regard, the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study has recently suggested a more inclusive classification scheme for myocardial infarction that takes into account the breadth of clinical phenotypes in young women and may serve as a future framework to better understand biological disease mechanisms, therapeutic efficacy, and prognosis in this population.15 So what does the future hold? Given the increasing proportion of young and middle-aged women being affected by CAD, it is imperative that we develop our knowledge of the young female cardiovascular phenotype and its vulnerability to cardiovascular disease. Under-representation of women in cardiovascular clinical trials has led to fundamental gaps in knowledge, and Gabet et al. now show us quite plainly the dimension of this problem. The higher numbers of young women suffering from CAD together with the ageing populations and women’s longer life span will increase morbidity and step up demands imposed on healthcare systems in the future. Therefore, it is crucial that we understand the biological, psychosocial, and demographic mechanisms contributing to worsening risk factor profiles in young women in order to address the plethora of unknowns that remain with regard to ACS in this population. Yentl’s gender-bending journey might lead us the way here: after having acquired more knowledge than any man, Yentl realized that being a woman is not necessarily a curse and traded back her pants for her skirt. This work was supported by grants from the Swiss National Science Foundation (SNSF), the Olga Mayenfisch Foundation, Switzerland, the Swissheart Foundation, and the OPO Foundation, Switzerland. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Cathérine Gebhard (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: